Beixcell
Changping · Founded 2020
About Beixcell
Beixcell develops off-the-shelf cell therapies for patients with many degenerative diseases through universal iPSCs-derived cell products.
Company Facts
- Founded: 2020
- Legal name: Beisai Hongsheng (Beijing) Biotechnology Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series Unknown (Jan 2023)
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/beixcell-8465101 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.